Myxofibrosarcoma primary cultures: molecular and pharmacological profile

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas

(2017) Federica Recine et al.   OncoTargets and Therapy

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group

(2016) A. Gronchi et al.   ANNALS OF ONCOLOGY

Surgical margins do not affect prognosis in high grade myxofibrosarcoma

(2016) A. Sambri et al.   EJSO

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

(2016) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma

(2016) Alessandro De Vita et al.   MOLECULES

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas

(2016) Alessandro De Vita et al.   OncoTargets and Therapy

Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma

(2016) Bo-Gen Ye et al.   Oncotarget

Innovative approaches to establish and characterize primary cultures: anex vivo3D system and the zebrafish model

(2016) Chiara Liverani et al.   Biology Open

Collagen-Hydroxyapatite Scaffolds Induce Human Adipose Derived Stem Cells Osteogenic Differentiation In Vitro

(2016) Giovanna Calabrese et al.   PLoS One

Soluble CD109 binds TGF-  and antagonizes TGF-  signalling and responses

(2015) C. Li et al.   BIOCHEMICAL JOURNAL

TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

(2015) Naoki Oshimori et al.   CELL

Prognostic impact of CD109 expression in myxofibrosarcoma

(2015) Makoto Emori et al.   JOURNAL OF SURGICAL ONCOLOGY

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma

(2015) Rita De Sanctis et al.   Drug Design Development and Therapy

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

(2014) Ian Judson et al.   LANCET ONCOLOGY

Multiscale Patterning of a Biomimetic Scaffold Integrated with Composite Microspheres

(2014) Silvia Minardi et al.   Small

CD109 is a potential target for triple-negative breast cancer

(2014) Ji Tao et al.   TUMOR BIOLOGY

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

(2013) Giovanni Germano et al.   CANCER CELL

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

(2013) Neil E. Bhola et al.   JOURNAL OF CLINICAL INVESTIGATION

High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma

(2013) Makoto Emori et al.   PLoS One

Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma

(2012) Nicole J. Look Hong et al.   ANNALS OF SURGICAL ONCOLOGY

The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors

(2011) Albane A. Bizet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution

(2010) Alessandro Gronchi et al.   ANNALS OF SURGERY

Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution

(2010) Roberta Sanfilippo et al.   ANNALS OF SURGICAL ONCOLOGY

Establishment of a primary human sarcoma model in athymic nude mice

(2010) Lars STEINSTRAESSER et al.   Human Cell

Recurrence Patterns and Survival for Patients With Intermediate- and High-Grade Myxofibrosarcoma

(2010) Karl E. Haglund et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A Review of Trabectedin (ET-743): A Unique Mechanism of Action

(2010) Maurizio D'Incalci et al.   MOLECULAR CANCER THERAPEUTICS

Processing of CD109 by furin and its role in the regulation of TGF-β signaling

(2010) S Hagiwara et al.   ONCOGENE

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering

(2009) Gráinne M. Cunniffe et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesothelioma

(2008) Yoshiaki Hagiwara et al.   CANCER SCIENCE

Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma

(2008) Shailendra Verma et al.   CANCER TREATMENT REVIEWS

Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms

(2008) Joshua Weaver et al.   MODERN PATHOLOGY

CD109 expression in basal-like breast carcinoma

(2008) Masaki Hasegawa et al.   PATHOLOGY INTERNATIONAL